Update to information on psychiatric disorders for chloroquine and hydroxychloroquine

EMA’s safety committee (PRAC) has recommended updating product information for all chloroquine or hydroxychloroquine-containing medicines following a review that confirmed a link between the use of these medicines and the risk of psychiatric disorders and suicidal behaviour.

European Medicines Agency